Using synthetic miRNA mimics for diverting cell fate: a possibility of miRNA-based therapeutics?
Ford
Lance P
LP
D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D053148:Caspase 3; D020169:Caspases / Q000187:drug effects / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008533:Megakaryocytes / Q000187:drug effects* / Q000378:metabolism; D035683:MicroRNAs / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D009841:Oligonucleotides / Q000138:chemical synthesis / Q000494:pharmacology*; D019284:Thapsigargin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013812:Therapeutics
D004791:Enzyme Inhibitors; D035683:MicroRNAs; D009841:Oligonucleotides; D019284:Thapsigargin; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases; D002118:Calcium